Poseida Therapeutics to Present anti-PSMA CAR-T Preclinical Data at the Society for Immunotherapy of Cancer (SITC … – Markets Insider
|
Poseida Therapeutics to Present anti-PSMA CAR–T Preclinical Data at the Society for Immunotherapy of Cancer (SITC …
Markets Insider “P‐PSMA‐101 is a CAR–T cell therapeutic that exhibits a persistently high percentage of stem cell memory T-cells and mediates durable anti‐solid tumor efficacy that surpasses previously established anti‐PSMA CAR T‐cell therapy in several in vivo models … |
